BC Platforms teams up with Sentieon
The decision to integrate the two companies’ technologies will enable BC Platforms to expand its solution both in cloud and on premise. Tero Silvola, CEO at BC Platforms, states that the partnership will “provide customers access to an end-to-end solution and the confidence to scale to any size” in delivering precision medicine.
Sentieon CEO Jun Ye sees the benefits of the partnership in a similar way: “Sentieon is thrilled to partner with one of the most experienced and respected genomic software companies in the world. Enabling precision medicine is a complex problem and by working together and combining each company’s core expertise we can better serve our customers.”
Read the entire article here.